-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Downgrades Boston Scientific to Hold, Lowers Price Target to $46

Benzinga·10/30/2026 18:26:11
Listen to the news
TD Cowen analyst Joshua Jennings downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $56 to $46.